The mammalian ortholog of Drosophila MOF that acetylates histone H4 lysine 16 is essential for embryogenesis and oncogenesis

被引:178
作者
Gupta, Arun [2 ]
Guerin-Peyrou, T. Geraldine [1 ]
Sharma, Girdhar G. [2 ]
Park, Changwon [2 ]
Agarwal, Manjula [2 ]
Ganju, Ramesh K. [3 ]
Pandita, Shruti [2 ]
Choi, Kyunghee [2 ]
Sukumar, Saraswati [4 ]
Pandita, Raj K. [2 ]
Ludwig, Thomas [1 ]
Pandita, Tej K. [2 ]
机构
[1] Columbia Univ, Inst Canc Genet, Dept Pathol & Cell Biol, New York, NY 10032 USA
[2] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63108 USA
[3] Harvard Univ, Sch Med, Boston, MA 02115 USA
[4] Johns Hopkins Univ, Sch Med, Baltimore, MD 21231 USA
关键词
D O I
10.1128/MCB.01045-07
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mammalian ortholog of the Drosophila MOF (males absent on the first) gene product is a histone H4 lysine 16-specific acetyltransferase. Recent studies have shown that depletion of human MOF (hMOF) in human cell lines leads to genomic instability, spontaneous chromosomal aberrations, cell cycle defects, altered nuclear morphology, reduced transcription of certain genes, and defective DNA damage response to ionizing radiation (IR). Here we show that MOF plays an essential role in mammals during embryogenesis and oncogenesis. Ablation of the mouse Mof gene (mMof) by gene targeting resulted in early embryonic lethality and cell death. Lethality correlated with the loss of H4 lysine 16 acetylation (H4K16ac) and could not be rescued by concomitant inactivation of ATM or p53. In comparison to primary cells or normal tissue, all immortalized human normal and tumor cell lines and primary tumors demonstrated similar or elevated hMOF and H4K16ac levels. Accordingly, MOF overexpression correlated with increased cellular proliferation, oncogenic transformation, and tumor growth. Thus, these data reveal that the acetylation of histone H4 at K16 by MOF is an epigenetic signature of cellular proliferation common to both embryogenesis and oncogenesis and that MOF is an essential factor for embryogenesis and oncogenesis.
引用
收藏
页码:397 / 409
页数:13
相关论文
共 50 条
[11]   Disruption of peripheral leptin signaling in mice results in hyperleptinemia without associated metabolic abnormalities [J].
Guo, Kaiying ;
McMinn, Julie E. ;
Ludwig, Thomas ;
Yu, Yi-Hao ;
Yang, Guoqing ;
Chen, Lulu ;
Loh, Daniella ;
Li, Cai ;
Chua, Streamson, Jr. ;
Zhang, Yiying .
ENDOCRINOLOGY, 2007, 148 (08) :3987-3997
[12]   Involvement of human MOF in ATM function [J].
Gupta, A ;
Sharma, GG ;
Young, CSH ;
Agarwal, M ;
Smith, ER ;
Paull, TT ;
Lucchesi, JC ;
Khanna, KK ;
Ludwig, T ;
Pandita, TK .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (12) :5292-5305
[13]   mof, a putative acetyl transferase gene related to the Tip60 and MOZ human genes and to the SAS genes of yeast, is required for dosage compensation in Drosophila [J].
Hilfiker, A ;
HilfikerKleiner, D ;
Pannuti, A ;
Lucchesi, JC .
EMBO JOURNAL, 1997, 16 (08) :2054-2060
[14]   Genome maintenance mechanisms for preventing cancer [J].
Hoeijmakers, JHJ .
NATURE, 2001, 411 (6835) :366-374
[15]  
HUNT CR, 1991, MOL CELL BIOL, V24, P599
[16]   SPECIFIC ASSOCIATION OF HUMAN TELOMERASE ACTIVITY WITH IMMORTAL CELLS AND CANCER [J].
KIM, NW ;
PIATYSZEK, MA ;
PROWSE, KR ;
HARLEY, CB ;
WEST, MD ;
HO, PLC ;
COVIELLO, GM ;
WRIGHT, WE ;
WEINRICH, SL ;
SHAY, JW .
SCIENCE, 1994, 266 (5193) :2011-2015
[17]   A decade of histone acetylation: Marking eukaryotic chromosomes with specific codes [J].
Kimura, A ;
Matsubara, K ;
Horikoshi, M .
JOURNAL OF BIOCHEMISTRY, 2005, 138 (06) :647-662
[18]   Acetylation by Tip60 is required for selective histone variant exchange at DNA lesions [J].
Kusch, T ;
Florens, L ;
MacDonald, WH ;
Swanson, SK ;
Glaser, RL ;
Yates, JR ;
Abmayr, SM ;
Washburn, MP ;
Workman, JL .
SCIENCE, 2004, 306 (5704) :2084-2087
[19]   Histone H4 acetylated at lysine 16 and proteins of the Drosophila dosage compensation pathway co-localize on the male X chromosome through mitosis [J].
Lavender, J. S. ;
Birley, A. J. ;
Palmer, M. J. ;
Kuroda, M. I. ;
Turner, B. M. .
CHROMOSOME RESEARCH, 1994, 2 (05) :398-404
[20]  
Morgan SE, 1997, ADV CANCER RES, V71, P1, DOI 10.1016/S0065-230X(08)60095-0